Christine Shan-Chi Chiu

Dr. Christine Shan-Chi Chiu

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CCChristine Shan-Chi Chiu
Christine Shan-Chi Chiu
LYling yu Yeh
ling yu Yeh
SPSZU-HUA PAN
SZU-HUA PAN
SLSheng-Hsiang Li
Sheng-Hsiang Li
Endometrial polyps (EPs) are benign overgrowths of the endometrial tissue lining the uterus, often causing abnormal bleeding or infertility. This study analyzed gene expression differences between EPs and adjacent endometrial tissue to elucidate intrinsic abnormalities promoting pathological overgrowth. RNA sequencing of 12 pairs of EPs and the surrounding endometrial tissue from infertile women revealed 322 differentially expressed genes. Protein–protein interaction network analysis revealed significant alterations in specific signaling pathways, notably Wnt signaling and vascular smooth muscle regulation, suggesting these pathways play critical roles in the pathophysiology of EPs. Wnt-related genes DKK1 and DKKL1 were upregulated, while GPC3, GREM1, RSPO3, SFRP5, and WNT10B were downregulated. Relevant genes for vascular smooth muscle contraction were nearly all downregulated in EPs, including ACTA2, ACTG2, KCNMB1, KCNMB2, MYL9, PPP1R12B, and TAGLN. Overall, the results indicate fundamental gene expression changes promote EP formation through unrestrained growth signaling and vascular defects. The intrinsic signaling abnormalities likely contribute to clinical symptoms of abnormal uterine bleeding and infertility common in EP patients. This analysis provides molecular insights into abnormal endometrial overgrowth to guide improved diagnostic and therapeutic approaches for this troublesome women’s health condition. Confirmation of expanded cohorts and further investigations into implicated regulatory relationships are warranted.

Verified
Journal Article
Open access
PDF file
LYling yu Yeh
ling yu Yeh
CCChristine Shan-Chi Chiu
Christine Shan-Chi Chiu
KLKuan-Sheng Lee
Kuan-Sheng Lee
RLRobert Kuo-Kuang Lee
Robert Kuo-Kuang Lee
MLMing-Huei Lin
Ming-Huei Lin
SLSheng-Hsiang Li
Sheng-Hsiang Li
In vitro maturation (IVM) of mammalian oocytes is an essential fertility option for patients at risk of ovarian hyperstimulation syndrome or needing urgent fertility preservation. However, poor outcomes indicate a limited understanding of the molecular mechanisms behind cumulus cell expansion and extracellular matrix (ECM) remodeling. This study investigated the role of serum-derived urokinase-type plasminogen activator (PLAU) in mouse oocyte IVM. Immature cumulus–oocyte complexes from CD-1 mice were cultured with or without serum, and PLAU activity was blocked using 4-chlorophenylguanidine hydrochloride. Cumulus expansion, oocyte maturation, and cumulus cell transcriptomes were analyzed. Serum supplementation enhanced cumulus expansion and maturation, while absence of serum or PLAU inhibition hindered both processes. External PLAU partially rescued these issues under serum-free conditions. Transcriptome analysis demonstrated that inhibiting PLAU activity reduces the expression of ovulation- and metabolism-related genes, such as those involved in glycolysis and carbohydrate metabolism, while increasing genes related to vesicle-mediated transport. PLAU is crucial for cumulus expansion and metabolic regulation during IVM, affecting ECM remodeling and oocyte quality. Supporting IVM culture media with proteolytic and metabolic factors could improve outcomes in assisted reproduction.

17 October 2026 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
SKShiho Kuji
Shiho Kuji
Mohd Faizal AhmadMohd Faizal Ahmad
Mohd Faizal Ahmad
SMSyamel Muhammad
Syamel Muhammad
SKsarita kumari
sarita kumari
RIRomelyn Imperio-Onglao
Romelyn Imperio-Onglao
NSNao Suzuki
Nao Suzuki
Kuji S, et al. J Gynecol Oncol. 2027 ;38:e21. https://doi.org/10.3802/jgo.2027.38.e21

17 October 2026 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
MYMasato Yoshihara
Masato Yoshihara
TSTingyan Shi
Tingyan Shi
NLNavamol Lekskul
Navamol Lekskul
ACAngela Cho
Angela Cho
BDBiswajit Dash
Biswajit Dash
NSNao Suzuki
Nao Suzuki
Yoshihara M, et al. J Gynecol Oncol. 2027 ;38:e17. https://doi.org/10.3802/jgo.2027.38.e17

17 October 2026 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
SKShiho Kuji
Shiho Kuji
SMSyamel Muhammad
Syamel Muhammad
SKsarita kumari
sarita kumari
RIRomelyn Imperio-Onglao
Romelyn Imperio-Onglao
Mohd Faizal AhmadMohd Faizal Ahmad
Mohd Faizal Ahmad
NSNao Suzuki
Nao Suzuki
Kuji S, et al. J Gynecol Oncol. 2027 ;38:e24. https://doi.org/10.3802/jgo.2027.38.e24